CN108201096A - 一种保健功能食用粉及其制备方法 - Google Patents
一种保健功能食用粉及其制备方法 Download PDFInfo
- Publication number
- CN108201096A CN108201096A CN201711472334.9A CN201711472334A CN108201096A CN 108201096 A CN108201096 A CN 108201096A CN 201711472334 A CN201711472334 A CN 201711472334A CN 108201096 A CN108201096 A CN 108201096A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- major ingredient
- garlic
- secondary feed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 93
- 238000002360 preparation method Methods 0.000 title abstract description 13
- 240000002234 Allium sativum Species 0.000 claims abstract description 36
- 235000004611 garlic Nutrition 0.000 claims abstract description 36
- 239000004615 ingredient Substances 0.000 claims abstract description 32
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 26
- 235000008397 ginger Nutrition 0.000 claims abstract description 26
- 244000068988 Glycine max Species 0.000 claims abstract description 25
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 25
- 244000105624 Arachis hypogaea Species 0.000 claims abstract description 24
- 235000020232 peanut Nutrition 0.000 claims abstract description 24
- 235000017060 Arachis glabrata Nutrition 0.000 claims abstract description 23
- 235000010777 Arachis hypogaea Nutrition 0.000 claims abstract description 23
- 235000018262 Arachis monticola Nutrition 0.000 claims abstract description 23
- 102000002322 Egg Proteins Human genes 0.000 claims abstract description 22
- 108010000912 Egg Proteins Proteins 0.000 claims abstract description 22
- 210000003278 egg shell Anatomy 0.000 claims abstract description 22
- 239000000463 material Substances 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 239000000203 mixture Substances 0.000 claims abstract description 3
- 241000234314 Zingiber Species 0.000 claims description 25
- 241001247821 Ziziphus Species 0.000 claims description 24
- 239000002245 particle Substances 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 12
- 230000018044 dehydration Effects 0.000 claims description 10
- 238000006297 dehydration reaction Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 6
- 238000005057 refrigeration Methods 0.000 claims description 6
- 239000002086 nanomaterial Substances 0.000 claims description 5
- 239000008280 blood Substances 0.000 abstract description 17
- 210000004369 blood Anatomy 0.000 abstract description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 11
- 239000008103 glucose Substances 0.000 abstract description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 6
- 206010028980 Neoplasm Diseases 0.000 abstract description 6
- 229910052791 calcium Inorganic materials 0.000 abstract description 6
- 239000011575 calcium Substances 0.000 abstract description 6
- 201000011510 cancer Diseases 0.000 abstract description 6
- 230000004224 protection Effects 0.000 abstract description 6
- 235000013376 functional food Nutrition 0.000 abstract description 3
- 238000012545 processing Methods 0.000 abstract description 3
- 235000013373 food additive Nutrition 0.000 abstract description 2
- 239000002778 food additive Substances 0.000 abstract description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 230000035764 nutrition Effects 0.000 abstract description 2
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 240000008866 Ziziphus nummularia Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 22
- 230000006870 function Effects 0.000 description 20
- 235000013305 food Nutrition 0.000 description 13
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 11
- 239000000126 substance Substances 0.000 description 10
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 7
- 229910001424 calcium ion Inorganic materials 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- 230000000050 nutritive effect Effects 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 3
- 235000010081 allicin Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000005253 cladding Methods 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 108090000312 Calcium Channels Proteins 0.000 description 2
- 102000003922 Calcium Channels Human genes 0.000 description 2
- 206010007559 Cardiac failure congestive Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000003205 diastolic effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical group N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- XUHLIQGRKRUKPH-GCXOYZPQSA-N Alliin Natural products N[C@H](C[S@@](=O)CC=C)C(O)=O XUHLIQGRKRUKPH-GCXOYZPQSA-N 0.000 description 1
- WNCAVNGLACHSRZ-KAMYIIQDSA-N Allithiamine Chemical compound C=CCSSC(/CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-KAMYIIQDSA-N 0.000 description 1
- WNCAVNGLACHSRZ-UHFFFAOYSA-N Allithiamine Natural products C=CCSSC(CCO)=C(C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-UHFFFAOYSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 101100343346 Drosophila melanogaster flz gene Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- XUHLIQGRKRUKPH-UHFFFAOYSA-N S-allyl-L-cysteine sulfoxide Natural products OC(=O)C(N)CS(=O)CC=C XUHLIQGRKRUKPH-UHFFFAOYSA-N 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- XUHLIQGRKRUKPH-DYEAUMGKSA-N alliin Chemical compound OC(=O)[C@@H](N)C[S@@](=O)CC=C XUHLIQGRKRUKPH-DYEAUMGKSA-N 0.000 description 1
- 235000015295 alliin Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000489 anti-atherogenic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000003822 cell turnover Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 238000005554 pickling Methods 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
- A23L11/07—Soya beans, e.g. oil-extracted soya bean flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L15/00—Egg products; Preparation or treatment thereof
- A23L15/30—Addition of substances other than those covered by A23L15/20 – A23L15/25
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/30—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
- A23L5/34—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation using microwaves
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种保健功能食用粉及其制备方法,属于功能食品技术领域。主要技术方案如下:一种保健功能食用粉,由如下原料制备而成,主料:100份,其中含大蒜20‑80份,其余为姜;副料:100份,由花生43‑52份,大豆25‑35份,大枣15‑18份,鸡蛋壳4‑8份组成。制备时,先将主料和副料粉碎成不同粒径大小的粉末,然后将主料粉末用副料粉末包覆以掩盖其特殊气味。本发明的制备过程不使用任何食品添加剂,采用纯机械的处理方式,制备的保健功能食用粉营养全面,还具有调节血糖、防癌、补钙的作用。
Description
技术领域
本发明属于功能食品技术领域,具体为一种保健功能食用粉及其制备方法。
背景技术
花生是全世界公认的健康食品,是长寿食品之一。花生中含有亚油酸,这种物质使人体内胆固醇分解为胆汁酸排出体外,避免胆固醇在体内沉积,减少引起多种心脑血管疾病。花生中的锌元素含量普遍高于其他油料作物。锌能促进儿童大脑发育,能增加大脑的反应能力;可激活中老年人脑细胞并延缓人体过早衰老;花生含钙量丰富,可促进儿童骨骼发育。花生中含有保健功能很强的天然多酚类物质-白藜芦醇。花生衣中含有油脂和多种纤维素,并含有促凝血缩短凝血时间的物质,有防纤维蛋白溶解,促进骨骼制造血小板的功能,对多种出血性疾病不但有止血作用,而且对原发病有一定的治疗作用,对人体造血功能有益。
黄豆俗称大豆,是一种众所周知的营养食品,大豆含有丰富的蛋白质,含有多种人体必须的氨基酸,可以提高人体免疫力。大豆中含有卵磷脂,可除去附在血管壁上的胆固醇,防止血管硬化,预防心脑血管疾病和保护心脏。大豆中的卵磷脂还具有防止心脏内积存过多的脂肪的作用,从而有效防止因肥胖而引起的脂肪肝;大豆中含有溶性纤维,既可通便又能降低胆固醇含量;大豆中含有一种能抑制胰酶的物质,对糖尿病有治疗作用;大豆中所含的皂甙有明显降低血脂的作用,同时还抑制体重增加,大豆异黄酮是一种结构与雌激素相似,具有雌激素溶性的植物性雌激素,能减轻女性更年期综合症,延迟女性细胞衰老,使皮肤保持弹性、并具有养颜及减少骨质丢失的作用,促进骨生成,降低血脂。
大枣能提高人体免疫力,能促进白细胞的生成,降低血清胆固醇提高血清白蛋白,保护肝脏。红枣中还有抑制癌细胞,甚至可使癌细胞向正常细胞转化的物质;大枣中维生素D含量是所有果蔬之最,其具有维持毛细管通透性,改善微循环,从而预防动脉硬化的作用,还可以调节人体代谢,增强人体免疫力,抗炎、抗变态反应,降低血糖和胆固醇含量等作用;所含芦丁有保护毛细管的通畅,防止血管壁脆化性增加,大枣能提高体内单核细胞的吞噬功能,有保护肝脏增加体力的作用,大枣中维生素C减轻化学药物对肝脏的损害,并有促进蛋白质合成增加血清蛋白含量的作用,大枣对它们有十分理想的食补作用,其效果通常是药物不能比拟的,大枣中的黄酮类物质可以防治脑缺症,并对脑力缺血所导致的脑组织超微结构损伤有保护作用,大枣中含有丰富的维生素C,维生素P对维护血管弹性,抗动脉粥样硬化很有益。
大蒜是营养保健价值非常高的食品,但是食用大蒜后会有难闻气味,目前食品领域对大蒜的加工技术还仅限于腌渍以掩盖其特殊气味。蛋壳的主要成分是碳酸钙,一般作为餐余垃圾丢弃,造成资源浪费,对蛋壳这种自然资源的开发利用不到位。
发明内容
为弥补现有技术的不足,本发明提供一种利用大蒜、鸡蛋壳、花生等材料制备的保健食用粉及其制备方法,具有食用、保藏方便,不含任何食品添加剂的特点。
本发明的技术方案如下:一种保健功能食用粉,由如下原料制备而成,主料:100份,其中含大蒜20-80份,其余为姜;副料:100份,由花生43-52份,大豆25-35份,大枣15-18份,鸡蛋壳4-8份组成。
进一步的,由如下原料制备而成,主料包括大蒜85份,姜15份;副料包括花生48份,大豆30份,大枣16份,鸡蛋壳6份。
本发明同时请求保护所述的保健功能食用粉的制备方法,该方法包括如下步骤:
S1:主料粉末制备
(1)将大蒜、姜分别进行去皮、清洗、消毒、切成5mm的颗粒后在50℃条件下烘干10min将原料脱水,脱水率为80%;烘干后粉碎成30目的粉末;
(2)将大蒜、姜粉末分别置于低温4℃冷藏10小时后,微波处理14s,所述微波处理功率为400W;所述大蒜和姜的颗粒先进行4℃冷藏再微波处理14s可使大蒜、姜的颗粒的内部结构发生变化,尤其是大蒜的气味显著降低,可能是由于微波处理时,颗粒内部与外表面温度不同,颗粒内部温度高,呈味物质向外挥发时,受到温度较低、分子运动不活跃的外表面阻挡,形成了类似于收紧口袋的封闭结构;
S2:副料粉末制备
(1)将花生、大豆、大枣分别清洗、在80-90℃下烘焙除去水分、粉碎成粒径为90-100nm的细粉,烘焙过程除去的水分占原材料比重的17%;
(2)将鸡蛋壳清洗、消毒、焙干、粉碎成粒径为8-9nm的细粉,纳米级别利于鸡蛋壳中碳酸钙的吸收。
(3)将花生,大豆,大枣,鸡蛋壳纳米细粉采用纳米材料混合机进行混合,即为副料粉末;
S3:主料粉末与副料粉末混合
混合将主料粉末与副料粉末按1:1的质量比混合,粒径小的副料粉末包裹粒径大的主料粉末即得到保健功能食用粉。主料粉末是30目,粒径大小约为590微米,副料粉末粒径是纳米级别,混合后颗粒大的主料粉末表面会吸附纳米级的副料粉末进而被包覆。
大蒜含有硫挥发物、酯类、肽类、苷类、酶类等物质,集近百种药用和保健成分一体,蒜氨酸是大蒜独有的成分,当它进入血液中便成为大蒜素,这种大蒜素即使在血液中被稀释10万倍,仍可瞬间杀死伤寒病菌、痢疾杆菌和流感病毒素。蒜素与维生素B1结合可生成蒜硫胺素,具有消除疲劳增强体力的奇效。大蒜含有有机酸酐是参与肌肉活动不可缺少的成分,对精液的成长也有作用,可大幅度增加精子的数量,所以吃大蒜能使精子旺盛。大蒜还能促新陈代谢,降低胆固醇和甘油三酯的含量,还有降低血压、降低血糖的作用,故对高血压、高血脂、高血糖有一定的疗效。大蒜还可以外用,可促使皮肤血液循环,去掉皮肤的老化角质,软化皮肤,增加弹性。还可防晒、防黑色素的沉积,去色增白。大蒜还可防癌,其效果在多种蔬菜、水果中居首位,在蒜的100多种成分中,其中几十种成分都有单独的抗癌性。
姜在民间有“生姜治百病”的说法,姜中含有姜醇、姜烯、姜素、水芹烯、柠檬醛和芳香等油性挥发物,还有姜辣素、树脂、淀粉和纤维素等。姜素具有一种特殊的功效,对血糖有双向调和作用。一方面使糖尿病患者的血糖降低,又能使患糖尿病的患者血糖升高。据资料介绍姜中含有与人类胰腺中生成胰岛素结构非常近的物质,当水中出现时,食用姜可以控制,说明姜有降低血糖的作用;然而当人体出现胰腺功能出现异常时,血糖低时,服用鲜姜以后,又能使血糖升高起到稳定和调节血糖的作用。
鸡蛋壳中含碳酸钙大约97%左右,在日本,鸡蛋壳被用来补钙,在我国被当成垃圾丢掉,污染环境。钙离子是维持机体细胞正常功能非常重要的离子,它对维持细胞膜两侧的生物电位,维持正常的神经传导功能,维持正常的肌肉伸缩与舒张功能,以及神经-肌肉传导功能,还有一些激素的作用机制,均通过钙离子表现出来。钙能维持正常的肌细胞功能,促进肌肉的收缩与舒张功能的正常,钙离子通过细胞膜上的钙离子通道进入细胞内,通过一系列生化反应,主要是加强心肌收缩力加快心率,加快传导作用,因而细胞外钙离子浓度高则会升高血压,使心收缩力加快,脉搏输出量较快,因而血压也会相应较高,主要的抗血压药物有抑制拮抗剂,它使钙离子通过细胞膜上的钙通道的数量减少,使得心肌收缩力减弱心率降低,血压下降。其他心血管系统疾病,还有充血性心力衰竭,心率失常等病因均与钙离子关系密切,钙离子对骨骼的生长发育有重要作用,在中青年时主要受激素的调节,老年人钙离子容易流失,因此骨骼变脆,变得容易骨折。
本发明所使用的材料是大众熟知的大蒜、姜、花生、黄豆、大枣、鸡蛋壳。这些原料食材各有特点,各有不同的营养价值、功效、作用。特别是大蒜虽然营养价值非常高,但是大蒜有一种难闻气味。因此本发明将上述材料进行改造,采用新技术、新工艺、进行科学的搭配与创新的包覆技术。副料花生、大豆粉末经焙烧熟后散发出香气,大枣粉末经焙烧熟后散发出甜味,用此副料对主料进行包覆使大蒜气味降到最低。这种副料与主料进行包覆技术和各食材之间的搭配配方到目前在食品领域还未见报道。
本发明的有益效果如下:
(1)本发明的制备过程只采取机械的、物理的处理技术,不使用任何其他化学物质,不添加任何添加剂,不接触任何污染,保持原料食材的原滋原味,制备的保健功能食品粉可以冲调也可以作为配料添加到其他食品中。
(2)本发明所用食材均含有对人体非常有益的多种营养成分,将这些食材经物理、机械加工并进行科学、合理不加任何添加剂的调制,不改变食材的原有营养价值、化学成分、性能和味道,只是对大蒜和姜的气味进行包覆、冲淡、掩盖,使味道降低到极低水平,不影响周围环境和人的接触。食用本发明食品较食用其中一种营养更全面,更多样化,各成分之间互补性更强,功效和作用更好,从而达到远离疾病,身体健康,生命长寿的效果。
(3)本发明集现代先进工艺、纯机械处理方法、科学的配方为一体,发挥综合性、协调性、互补性的作用,也借鉴了中医中药配方的科学原理的优点,将其优点、特点展示出来。
(4)本发明制备过程将原材料进行微波和包覆处理,对大蒜的气味进行了掩盖和包覆,六种食材各有独特的营养价值、功效和作用,再进行科学的搭配和科学的工艺加工,使其各自的营养价值、功效和作用获得相互融合,相互互补,相互促进,作用功效增强,制备的产品也更易被接受,还具有调节血糖、防癌、补钙的作用。
具体实施方式
下面结合具体实施例对本发明的技术方案作进一步的说明,但本发明不以任何形式受限于实施例内容。实施例中所述试验方法如无特殊说明,均为常规方法;如无特殊说明,所述试剂和化学材料,均可从商业途径获得。
实施例1
S1:主料粉末制备
(1)将大蒜80份、姜20份分别进行去皮、清洗、消毒、切成5mm的颗粒后在50℃条件下烘干10min将原料脱水,脱水率为80%;烘干后粉碎成30目的粉末;
(2)将大蒜、姜颗粒分别置于低温4℃冷藏2小时后,微波处理14s,所述微波处理功率为400W;
S2:副料粉末制备
(1)将花生43份、大豆35份、大枣15份分别清洗、在80℃下烘焙除去水分、粉碎成粒径为90nm的细粉,烘焙过程除去的水分占原材料比重的17%;
(2)将鸡蛋壳7份清洗、消毒、焙干、粉碎为8nm的纳米细粉;
(3)将花生,大豆,大枣,鸡蛋壳纳米细粉采用纳米材料混合机进行混合,即为副料粉末;
S3:主料粉末与副料粉末混合
将主料粉末与副料粉末按1:1的质量比混合,粒径小的副料粉末包裹粒径大的主料粉末即得到保健功能食用粉。
实施例2
S1:主料粉末制备
(1)将大蒜20份、姜80份分别进行去皮、清洗、消毒、切成5mm的颗粒后在50℃条件下烘干10min将原料脱水,脱水率为80%;烘干后粉碎成30目的粉末;
(2)将大蒜、姜颗粒分别置于低温4℃冷藏2小时后,微波处理14s,所述微波处理功率为400W;
S2:副料粉末制备
(1)将花生52份、大豆25份、大枣15份分别清洗、在80℃下烘焙除去水分、粉碎成粒径为100nm的细粉,烘焙过程除去的水分占原材料比重的17%;
(2)将鸡蛋壳8份清洗、消毒、焙干、粉碎为9nm的纳米细粉;
(3)将花生,大豆,大枣,鸡蛋壳纳米细粉采用纳米材料混合机进行混合,即为副料粉末;
S3:主料粉末与副料粉末混合
将主料粉末与副料粉末按1:1的质量比混合,粒径小的副料粉末包裹粒径大的主料粉末即得到保健功能食用粉。
实施例3
S1:主料粉末制备
(1)将大蒜85份、姜15份分别进行去皮、清洗、消毒、切成5mm的颗粒后在50℃条件下烘干10min将原料脱水,脱水率为80%;烘干后粉碎成30目的粉末;
(2)将大蒜、姜颗粒分别置于低温4℃冷藏2小时后,微波处理14s,所述微波处理功率为400W;
S2:副料粉末制备
(1)将花生48份、大豆30份、大枣16份分别清洗、在80℃下烘焙除去水分、粉碎成粒径为100nm的细粉,烘焙过程除去的水分占原材料比重的17%;
(2)将鸡蛋壳6份清洗、消毒、焙干、粉碎为9nm的纳米细粉;
(3)将花生,大豆,大枣,鸡蛋壳纳米细粉采用纳米材料混合机进行混合,即为副料粉末;
S3:主料粉末与副料粉末混合
将主料粉末与副料粉末按1:1的质量比混合,粒径小的副料粉末包裹粒径大的主料粉末即得到保健功能食用粉。
上述实施例仅用于解释说明本发明的发明构思,而非对本发明权利保护的限定,凡利用此构思对本发明进行非实质性的改动,均应落入本发明的保护范围。
Claims (3)
1.一种保健功能食用粉,其特征在于,由如下原料制备而成:
主料:100份,其中含大蒜20-80份,其余为姜;
副料:100份,由花生43-52份,大豆25-35份,大枣15-18份,鸡蛋壳4-8份组成。
2.如权利要求1所述的保健功能食用粉,其特征在于,由如下原料制备而成:
主料:100份,其中含大蒜85份,姜15份;
副料:100份,其中花生48份,大豆30份,大枣16份,鸡蛋壳6份。
3.一种制备如权利要求1所述的保健功能食用粉的方法,其特征在于,包括如下步骤:
S1:主料粉末制备
(1)将大蒜、姜分别进行去皮、清洗、消毒、切成5mm的颗粒后在50℃条件下烘干10min将原料脱水,脱水率为80%;烘干后粉碎成30目的粉末;
(2)将大蒜、姜颗粒分别置于低温4℃冷藏2小时后,微波处理14s,所述微波处理功率为400W;
S2:副料粉末制备
(1)将花生、大豆、大枣分别清洗、在80-90℃下烘焙除去水分、粉碎成粒径为90-100nm的细粉,烘焙过程除去的水分占原材料比重的17%;
(2)将鸡蛋壳清洗、消毒、焙干、粉碎成粒径为8-9nm的细粉;
(3)将花生,大豆,大枣,鸡蛋壳纳米细粉采用纳米材料混合机进行混合,即为副料粉末;
S3:主料粉末与副料粉末混合
将主料粉末与副料粉末按1:1的质量比混合,粒径小的副料粉末包裹粒径大的主料粉末即得到保健功能食用粉。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711472334.9A CN108201096A (zh) | 2017-12-29 | 2017-12-29 | 一种保健功能食用粉及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711472334.9A CN108201096A (zh) | 2017-12-29 | 2017-12-29 | 一种保健功能食用粉及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108201096A true CN108201096A (zh) | 2018-06-26 |
Family
ID=62605609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711472334.9A Pending CN108201096A (zh) | 2017-12-29 | 2017-12-29 | 一种保健功能食用粉及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108201096A (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0716072A (ja) * | 1992-03-18 | 1995-01-20 | Bizen Kasei Kk | マイクロ波処理による無臭ニンニクエキスの製造法 |
JPH08298955A (ja) * | 1995-04-28 | 1996-11-19 | Meiji Yakuhin Kk | にんにくの臭いの軽減化法 |
CN1628639A (zh) * | 2004-07-21 | 2005-06-22 | 朱芳海 | 固体口服药物制剂不良味觉的掩盖技术 |
CN103341091A (zh) * | 2013-06-27 | 2013-10-09 | 成都乾坤动物药业有限公司 | 一种促进畜禽生长的中药粒子设计散及其制备方法 |
CN104738615A (zh) * | 2013-12-27 | 2015-07-01 | 王金山 | 一种无臭大蒜粉技术 |
CN106036638A (zh) * | 2016-07-04 | 2016-10-26 | 徐州工程学院 | 一种复合大蒜粉的加工方法 |
CN106173934A (zh) * | 2016-06-28 | 2016-12-07 | 禹州市思源实业有限公司 | 一种手术后康复营养手盘面及其制备方法 |
-
2017
- 2017-12-29 CN CN201711472334.9A patent/CN108201096A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0716072A (ja) * | 1992-03-18 | 1995-01-20 | Bizen Kasei Kk | マイクロ波処理による無臭ニンニクエキスの製造法 |
JPH08298955A (ja) * | 1995-04-28 | 1996-11-19 | Meiji Yakuhin Kk | にんにくの臭いの軽減化法 |
CN1628639A (zh) * | 2004-07-21 | 2005-06-22 | 朱芳海 | 固体口服药物制剂不良味觉的掩盖技术 |
CN103341091A (zh) * | 2013-06-27 | 2013-10-09 | 成都乾坤动物药业有限公司 | 一种促进畜禽生长的中药粒子设计散及其制备方法 |
CN104738615A (zh) * | 2013-12-27 | 2015-07-01 | 王金山 | 一种无臭大蒜粉技术 |
CN106173934A (zh) * | 2016-06-28 | 2016-12-07 | 禹州市思源实业有限公司 | 一种手术后康复营养手盘面及其制备方法 |
CN106036638A (zh) * | 2016-07-04 | 2016-10-26 | 徐州工程学院 | 一种复合大蒜粉的加工方法 |
Non-Patent Citations (1)
Title |
---|
张郁松 等: "大蒜脱臭方法的研究", 《中国调味品》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2367464C2 (ru) | Состав для лечения хронических венозных недостаточностей, содержащий водный экстракт листьев красного винограда и противовоспалительное средство | |
CN101642247B (zh) | 一种降脂降压方便食品及其加工方法 | |
KR101723206B1 (ko) | 흰점박이 꽃무지 유충 추출물을 함유하는 건강보조식품용 환 및 그의 제조방법 | |
US10076548B2 (en) | Mixture powders of platycodon grandifloras and momordica charantia, and method for producing the powders | |
CN112056459A (zh) | 大蒜提取物的制备方法及其复合天然植物提取物添加剂 | |
CN101147527B (zh) | 一种能使鸭蛋具有软化血管和降压作用的饲料及制备方法 | |
CN106362125A (zh) | 一种保健足贴及其使用方法 | |
JP2011020925A (ja) | 内臓脂肪型肥満抑制剤及びその製造方法 | |
KR101642176B1 (ko) | 성장촉진 조성물 | |
KR20130010922A (ko) | 혈당강하 효능이 있는 생약 조성물 및 그의 제조 방법 | |
CN108201096A (zh) | 一种保健功能食用粉及其制备方法 | |
KR20200018885A (ko) | 생누에를 이용한 식품원료의 가공방법 | |
KR20100006702A (ko) | 흑 마늘 즙의 제조방법 및 제품 | |
KR100466946B1 (ko) | 오리 사육용 사료 및 이를 이용한 오리의 사육방법 | |
CN105475581B (zh) | 一种玫瑰茄保健袋泡茶及其制备方法 | |
CN105410755A (zh) | 一种红薯叶即食制品的加工方法 | |
CN105211881A (zh) | 一种具有增强免疫力功能的保健食品及其生产方法 | |
KR20050080501A (ko) | 고혈압, 비만, 당뇨병환자를 위한 건강보조식품의 제조방법 | |
CN107412445A (zh) | 一种柏枝茶油止血膏及用法食品药膏日化品理疗药膏 | |
CN104431934A (zh) | 一种茶籽油蒜泥调料 | |
CN107510748A (zh) | 一种柏枝茶油止血液及用法食品药液日化品理疗药液 | |
CN103829308A (zh) | 一种蒜味饮料 | |
CN103653033A (zh) | 一种醋蛋粉的制备方法 | |
KR102214624B1 (ko) | 항비만용 조성물 | |
CN107397837A (zh) | 一种松皮茶油烧烫伤液及用法食品药液日化品理疗药液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180626 |